•
Mar 31, 2018

CRISPR Therapeutics Q1 2018 Earnings Report

Total Revenue
$1.36M
Previous year: $2.7M
-49.8%
EPS
-$0.62
Previous year: -$0.54
+14.8%
Gross Profit
-$18.2M
Previous year: -$12.1M
+50.1%
Cash and Equivalents
$342M
Previous year: $289M
+18.3%
Free Cash Flow
-$23.2M
Total Assets
$374M
Previous year: $322M
+16.2%

CRISPR Therapeutics

CRISPR Therapeutics